Amniotic fluid chromosome 9 short arm?
Hello Doctor, the results of the amniocentesis genetic testing indicate that the sample consists of female components with X chromosome sequences.
However, there is a deletion of a 2.34 Mb microdeletion in the short arm of chromosome 9 at the p24.3p24.2 region.
This may also represent a benign variant.
The deleted segment includes six OMLM genes: DMRT1, DMRT2, DMRT3, DOCK8, KANK1, and SMARCA2.
I would like to inquire about the potential impacts on the child.
Will they be healthy? Are there any long-term effects? What does benign variant mean?
Di yi tai ma ma, 30~39 year old female. Ask Date: 2018/08/10
Dr. Chen Ming reply Rare Disease
You can consult a renowned obstetrician in the area, or call 04-7238595 extension 7244 to schedule an appointment.
Reply Date: 2018/08/10
More Info
Understanding chromosomal deletions, particularly in the context of the 9p24.3p24.2 region, is crucial for assessing potential health impacts on an individual. The results of your amniocentesis indicate a deletion of a 2.34 Mb microdeletion in this specific chromosomal region, which encompasses several important genes: DMRT1, DMRT2, DMRT3, DOCK8, KANK1, and SMARCA2.
Implications of the Deletion
1. Gene Functions:
- DMRT Genes: These genes are involved in sex determination and development. DMRT1, for instance, plays a significant role in male sex differentiation. Deletions in these genes may lead to reproductive or developmental issues, although the exact impact can vary widely.
- DOCK8: This gene is crucial for immune function. Deletions here can lead to immunodeficiency, increasing susceptibility to infections.
- KANK1: This gene is involved in cellular processes, including cytoskeletal organization and cellular signaling. Its deletion may have implications for cellular function and development.
- SMARCA2: This gene is involved in chromatin remodeling and gene expression regulation, which can affect various developmental processes.
2. Potential Health Impacts:
- The specific health impacts of this deletion can vary significantly depending on the extent of the deletion and the function of the affected genes. Some individuals with similar deletions may experience developmental delays, learning disabilities, or physical anomalies, while others may be asymptomatic.
- The presence of the deletion does not automatically indicate that the child will have health issues. Many individuals with chromosomal deletions lead healthy lives, particularly if the deletion is classified as benign.
Understanding Benign Variants
The term "benign variant" refers to genetic changes that do not appear to cause any health problems or increase the risk of disease. In the context of your results, this means that while the deletion is present, it may not have any significant impact on the child's health or development. Geneticists often classify variants as benign based on population studies and the absence of associated health conditions in individuals with similar genetic changes.
Monitoring and Follow-Up
1. Genetic Counseling: It is advisable to consult with a genetic counselor or a medical geneticist. They can provide a more detailed interpretation of the results, discuss the implications for the child, and help you understand the potential for any health issues.
2. Regular Health Check-ups: If the deletion is confirmed, regular pediatric check-ups are recommended to monitor the child’s development and health. Early intervention can be beneficial if any developmental delays or health issues arise.
3. Further Testing: Depending on the clinical findings and family history, further genetic testing may be warranted to assess for additional abnormalities or to clarify the implications of the deletion.
Conclusion
In summary, the deletion in the 9p24.3p24.2 region may have varying implications for health, depending on the specific genes involved and the nature of the deletion. While there is a potential for health impacts, many individuals with similar genetic findings can lead healthy lives. Engaging with healthcare professionals specializing in genetics will provide the best guidance and support for understanding and managing any potential health implications for your child.
Similar Q&A
Understanding the Impact of Chromosome 15q11.2 Microdeletions on Rare Diseases
The deletion at 138275 is located at the long arm of chromosome 15, specifically at q11.2, within the region from 22,770,421 to 23,282,798, which corresponds to OMIM (615656). What potential impacts could this have? The blood test has confirmed it is hereditary, but the mother is...
Dr. Chen Ming reply Rare Disease
Please scan your report and send it to [email protected]. Additionally, call 04-7238595 ext. 7244 to request assistance from a genetic counselor to add me to the Chang Gung Memorial Hospital outpatient clinic. God bless you. [The case results do not specify the genome version...[Read More] Understanding the Impact of Chromosome 15q11.2 Microdeletions on Rare Diseases
Understanding the Impact of 7q11.22 Deletion on Baby's Health
Dear Doctor, I recently underwent amniocentesis, and it was found that my baby girl has a deletion of a 252 kb segment on the long arm of chromosome 7 at the 7q11.22 region (69,521,716_69,773,395), which happens to be within the AUTS2 gene, encompassing the 3rd and 4th exons nea...
Dr. Chen Ming reply Rare Disease
Please call 04-7238595 extension 7244 to arrange an outpatient appointment. Wait for the results for your parents to come in together.[Read More] Understanding the Impact of 7q11.22 Deletion on Baby's Health
Impact of Chromosome 16p13.11 Deletion on Fetal Development and Screening
Hello, this amniotic fluid chip has confirmed a primary mutation. I would like to ask if there are any case numbers in Taiwan that can be referenced regarding the impact of this deletion on the fetus? The mention of an expressivity rate of 13.1%—is that considered high? If the co...
Dr. Jian Yingxiu reply Rare Disease
The 16p13.11 microdeletion is currently known to potentially cause developmental delays, learning disabilities, or epilepsy; however, there are also reports of asymptomatic cases. Therefore, it is not a condition with a 100% penetrance. Additionally, since the range and size of t...[Read More] Impact of Chromosome 16p13.11 Deletion on Fetal Development and Screening
Impact of Chromosome 17 Rearrangement on Child Development at 9 Months
Hello Dr. Zhao, I would like to ask about a 9-month-old child with an inversion of the 17th chromosome. Will this have any impact on the child? What conditions can arise from abnormalities in the 17th chromosome, such as deletions, duplications, inversions, etc.?
Dr. Zhao Yongkang reply Pediatrics
Hello, Miss: A partial deletion of chromosome 17 can lead to issues such as cerebellar ataxia, a narrow forehead, clefts, short stature, growth retardation, and intellectual disabilities. However, in some cases of chromosome 17 translocation, certain children may be carriers with...[Read More] Impact of Chromosome 17 Rearrangement on Child Development at 9 Months
Related FAQ
(Rare Disease)
Whole Exome Sequencing(Rare Disease)
Height(Rare Disease)
G6Pd Deficiency(Rare Disease)
Rare Disease Treatment(Rare Disease)
Osteogenesis Imperfecta(Rare Disease)
Congenital Metabolic Disorders(Rare Disease)
Newborn Screening(Rare Disease)
Ichthyosis(Rare Disease)
Tourette Syndrome(Rare Disease)